Bacteria, viruses, and parasites are harmful microorganisms that cause infectious diseases.
Early detection of diseases is critical to prevent disease transmission and provide epidemic …

Viruses are responsible for multiple infections in humans that impose huge health burdens
on individuals and populations worldwide. Therefore, numerous diagnostic methods and …

Since its first discovery in December 2019, the global coronavirus disease 2019 (COVID-19)
pandemic caused by the novel coronavirus (SARS-CoV-2) has been posing a serious threat …

The acceptability and feasibility of large-scale testing with lateral flow tests (LFTs) for clinical
and public health purposes has been demonstrated during the COVID-19 pandemic. LFTs …

Technologies based on lateral flow immunoassay (LFIA), known in some countries of the
world as immunochromatographic tests, have been successfully used for the last six …

The outbreak of the coronavirus disease 2019 (COVID-19) has resulted in enormous losses
worldwide. Through effective control measures and vaccination, prevention and curbing …

Lateral flow tests are one of the most important types of paper-based point-of-care (POCT)
diagnostic tools. It shows great potential as an implement for improving the rapid screening …

Up-to-date diagnostics is globally improved by point-of-care testing (POCT) analysis and
bedside research works. Development in POCT analysis has been provided mostly by …

Lateral flow assays (LFAs) hold great promise for point-of-care testing, especially in
resource-poor settings. However, the poor sensitivity of LFAs limits their widespread …

Background Lateral flow immunoassays are widely used as diagnostic tests in many
applications in human and other diagnostic areas. Assays for human applications have …